PRIVI SPECIALITY CHEMICALS LIMITED Annual Report 2020-21

60 PRIVI SPECIALITY CHEMICALS LIMITED (Formerly known as Fairchem Speciality Limited) e. CEO / CFO Certification The requisite certification from the Chairman & Managing Director and the Chief Financial Officer required to be given under Regulation 17(8) read with part B of schedule II of the Listing Regulations, was placed before the Board of Directors of the Company. f. Recommendation of Committees The Board of Directors of the Company has accepted all the recommendations of the Committees of the Board. g. Certificate from Company Secretary in Practice The Company has availed the certificate from M/s. Rathi & Associates, Companies Secretaries in Practice that none of the Directors of the Company have been debarred or disqualified from being appointed or re-appointed or continuing as a Directors of the Companies by SEBI, MCA or other regulatory authorities and the same is attached to this Annual report. h. Consolidated Fees paid to Statutory Auditors. During the year, total fees of ` 70.25 Lakhs was paid by the Company to M/s. B S R & Co. LLP, Statutory Auditors. i. Disclosure in relation to the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 The Company has in place a Policy on Sexual harassment at workplace which aims at protecting the women employees at workplace and to redress their complaints. During the year under review the Company has not received any complaint under Sexual harassment of women at workplace. j. Legal Compliance The Company is committed to and conducts its business activities lawfully and in a manner that is consistent with its compliance obligations while ensuring standards of good corporate governance, ethics and community expectations. Through a Legal Compliance Management software, your Company maintains an appropriate compliance program which manages, reports and monitors compliance with all laws which are applicable to the Company. k. Non-Mandatory requirements adopted: The Company has complied with non-mandatory requirements of the Listing Regulations relating to Corporate Governance. i. During the year under review, there was no Audit qualification in the Company’s Financial Statements. The Company adopts best practices to ensure a regime of un-modified audit opinion. ii. The Internal Auditors of the Company reports to the Audit Committee 10. Subsidiaries During the year under review, the Company has two wholly owned subsidiaries namely: a) Privi Biotechnologies Private Limited b) Privi Organics USA Corp. Privi Organics USA Corp is a material Unlisted Subsidiary incorporated in New Jersey, USA. The minutes of the Meeting of the Board of Directors of Subsidiaries / Performance is placed before the Board of Directors for review on a quarterly basis. The policy on determination of Material Subsidiary of the Company is available on the Company’s website at http:// www.privi.com/Downloads/Policies-PSCL/PSCL-Policy-on-Material-Subsidiary.pdf . 11. Means of Communication. The Company has promptly reported all material information including declaration of quarterly financial results, press releases etc. to stock exchanges where shares of the Company are listed. Such information is also simultaneously displayed on the Company’s website www.privi.com .